A randomised double-blind placebo-controlled multicentre study to assess cardiovascular outcomes following treatment with MK-3102 in subjects with type 2 diabetes mellitus

  • Simpson, Richard (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/06/13 → 5/11/14